Integra warns impact of plant closure will continue into 2024, with delays possible

Management has built a buffer into the plan but cautioned unforeseen events could cause its timeline to slip.

Medtechdive

Vicarious expects to perform first human procedure with robot next year

The company, after disclosing layoffs in February, said it has gained clarity on its regulatory pathway following pre-submission meetings with the FDA.

Medtechdive

Integra warns impact of plant closure will continue into 2024, with delays possible

Management has built a buffer into the plan but cautioned unforeseen events could cause its timeline to slip.

Medtechdive

Abbott pulls Trifecta heart valves from US market over deterioration rate

The action removes a rival to Edwards Lifesciences and Medtronic for the surgical aortic valve replacement market.

Medtechdive


Vicarious expects to perform first human procedure with robot next year

The company, after disclosing layoffs in February, said it has gained clarity on its regulatory pathway following pre-submission meetings with the FDA.

Medtechdive

Abbott pulls Trifecta heart valves from US market over deterioration rate

The action removes a rival to Edwards Lifesciences and Medtronic for the surgical aortic valve replacement market.

Medtechdive



Scroll to Top